NYSE - Delayed Quote USD
McKesson Corporation (MCK)
994.58 +13.70 (+1.40%)
At close: October 30 at 4:00:02 PM EDT
994.58 0.00 (0.00%)
After hours: October 30 at 4:05:21 PM EDT
Trade MCK on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for MCK
What's happening with MCK?
Powered by Yahoo ScoutMcKesson approaches its November 4 fiscal second-quarter report with analysts expecting higher earnings and revenue. The investment debate centers on pharmaceutical distribution strength, oncology and technology growth, valuation, and whether cash generation can support reinvestment and dividends.
Powered by Yahoo Scout
- Previous Close
980.88 - Open
1,006.29 - Bid 993.47 x 8000
- Ask 993.65 x 40000
- Day's Range
990.30 - 1,016.60 - 52 Week Range
723.68 - 1,030.27 - Volume
763,112 - Avg. Volume
867,014 - Market Cap (intraday)
115.958B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
26.66 - EPS (TTM)
37.31 - Earnings Date Nov 4, 2026
- Forward Dividend & Yield 3.76 (0.38%)
- 1y Target Est
1,026.07 - Morningstar Rating Rating available with Stock Picks access
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
MCK
21.61%
S&P 500 (^GSPC)
10.73%
1-Year Return
MCK
20.95%
S&P 500 (^GSPC)
11.11%
3-Year Return
MCK
124.25%
S&P 500 (^GSPC)
81.91%
5-Year Return
MCK
390.93%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/30/2026
Market Cap
115.96B
Enterprise Value
125.43B
Trailing P/E
26.66
Forward P/E
22.20
PEG Ratio (current)
1.37
Price/Sales (ttm)
0.30
Price/Book (mrq)
--
Enterprise Value/Revenue
0.31
Enterprise Value/EBITDA
17.13
Financial Highlights
Profitability and Income Statement
Profit Margin
1.12%
Return on Assets (ttm)
4.74%
Return on Equity (ttm)
--
Revenue (ttm)
410.98B
Net Income Avi to Common (ttm)
4.59B
Diluted EPS (ttm)
37.31
Balance Sheet and Cash Flow
Total Cash (mrq)
5.16B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
6.8B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreMcKesson: Another Specialty Asset Acquisition Fits With Long-Term Ambition; Valuation Maintained
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
On Monday, the Nasdaq, Nasdaq 100 (QQQ), and iShares Top U.S.
On Monday, the Nasdaq, Nasdaq 100 (QQQ), and iShares Top U.S. Stocks ETF (TOPT) added to their advances and pushed deeper into uncharted territory. That means we now have confirmed breakouts. Meanwhile the S&P 500 (SPX) could soon eclipse its August 13 all-time high (ATH) at 7,800. The smaller-cap indices have bounced off their respective 200-day averages, a bullish sign, but have a lot of ground to recover before we can start talking about ATHs. The 10-year Treasury rose a few basis points to 5.3%, while the rest of the yield curve did little. That is at least a small victory considering the recent run higher. One gets the sense that the stock market could see a blow-off move if yields just see some reversion to the mean. It's pretty clear that the suffering market breadth condition would get quite a boost on any indication that rates have topped. Many times, when breadth and many stocks and industries become extremely oversold, the snapback is particularly sharp.
McKesson and Cardinal Health: CVS Contract Renewal Reaffirms Narrow Moat and Long-Term Growth
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Raising target price
McKesson, which is headquartered in Irving, Texas, operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical (until spun-off).